LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...

After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...

Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues- Astellas to lead commercialization of VIR-5500 in the U.S. with Vir Biotechnology ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

The first three months of 2026 saw 14 companies announce cuts. That's a ramp-up from the prior quarter, which saw 476 workers ...

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...

Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...

You won’t want to miss 29th Annual A Taste of Spring Benefiting NUPATH and Woburn Host Lions Charities on the Woburn Patch calendar ...